ALIBABA-CLOUD
9.1.2023 07:58:17 CET | Business Wire | Press release
Alibaba Cloud, the digital technology and intelligence backbone of Alibaba Group (NYSE: BABA; HKEX: 9988), today unveiled at the Alibaba Cloud Singapore Summit 2023 its first international product innovation center and partner management center, to further enhance customer services and better facilitate customers’ digitalization journey.
The new Product Innovation Center will help facilitate future roadmaps for developing more market-specific solutions, and will oversee the management of product upgrades based on ongoing global customer demands. To better serve local customers’ needs, the Partner Management Center will be launched to delve into local collaborations to deepen the sharing of leading technologies and domain expertise amongst partners.
These new initiatives will not only create more job opportunities for local talents in Singapore but will also enhance more local collaborations through the creation of a new Innovation Accelerator Program to support businesses to expand as the global digital economy continues to grow.
The Innovation Accelerator Program aims to bring together industry leaders and experts to help develop more innovative and resilient businesses in Singapore through sharing of practical skills and ideas, and providing ease of access to the latest cloud technologies. Each eligible company under the program will also receive complimentary training and technical support from Alibaba Cloud and industry experts.
By supporting businesses with their digital transformation and innovation journey through upskilling, retraining, and technical upgrading, the program also provides them with an opportunity to plug into the dynamic global ecosystem of Alibaba Cloud, which is designed to further empower businesses to explore and realize their growth ambitions not only locally but also internationally.
“Today we are in a very early stage of digitalization,” said Dr. Wang Jian, Member of Chinese Engineering Academy and founder of Alibaba Cloud. “In the next five to ten years, the economy is going to be driven and measured by computing consumption. Digital economy is the economy of computing, and cloud computing will play the same role in the era of digitalization as electricity played in the era of electrification. The cloud is becoming a methodology not just for cloud computing, but a methodology for most people doing their work.”
In a bid to complement sustainable business strategies, Alibaba Cloud will also be working with partners to help 10,000 global companies to accelerate their sustainability journey over the next three years. Businesses in Singapore will be offered a pilot program of Energy Expert to help reduce their carbon footprints. A proprietary software-as-a-service sustainability platform launched by Alibaba Cloud in June last year, Energy Expert helps measure, analyze, and manage the carbon emissions of business activities and products while providing actionable insights and energy-saving recommendations to companies in helping them achieve their carbon emission goals.
“With the setup of our first International Product Innovation Center and Partner Management Center in Singapore, our global headquarters for Alibaba Cloud, we are committed to continuously supporting global businesses in their digital transformation journey. The new initiatives and the strengthening of our talented workforce further illustrate our support for global customers with ambitions to expand and upgrade their innovation capabilities, while delivering on their sustainability goals,” said Selina Yuan, Vice President of Alibaba Group and President of Alibaba Cloud Intelligence International Business Unit.
Attaining the highest tier of CSA cybersecurity certification
A critical part of Alibaba Cloud’s continuous efforts is to bring better services and offerings to businesses and these include enhanced cybersecurity and protection for customers. Alibaba Cloud has recently attained the Cyber Trust (Advocate) mark certification. The Cyber Trust mark, developed by the Cyber Security Agency of Singapore (CSA), is targeted at larger or more digitalized organizations, and helps organizations to communicate their investment in cybersecurity as a competitive edge and to build trust with their customers.
The Cyber Trust (Advocate) mark is the highest tier of the certification. It affirms Alibaba Cloud’s dedication to offer trusted services for businesses to manage and protect their cloud infrastructure.
Supporting Customers’ Growth with Technology for Innovation
Gadget MIX is a Singapore-based retailer with more than 20 outlets across the country and a robust e-commerce presence that focuses on high-tech digital products. Alibaba Cloud has helped Gadget MIX digitally transform its retail strategy through providing innovative cloud solutions. Partnering with Alibaba Cloud has allowed Gadget MIX to improve internal communications, streamline business operations, and seamlessly migrate to the cloud to speed up its business transformation.
“The solutions provided by Alibaba Cloud have helped to lower our total cost of ownership and streamline business operations, thus speeding up our business transformation efforts. In particular, the deployment of DingTalk has helped us to improve workflow management and team collaborations as well as our business and internal communications. Through our digital transformation efforts together with Alibaba Cloud, we have succeeded in creating more value for our retail customers and look forward to future collaborations around digital transformation,” said Ray Yue, CEO of Gadget MIX.
Leveraging Alibaba Cloud’s game accelerator solution and security products like Game Shield and Anti-DDos, Project Twelve (P12), a web3 gaming platform headquartered in Singapore, is now able to focus on scalable game deployment while providing a secure environment for their users by lowering the risks of cyberattacks. P12 also utilizes Alibaba Cloud’s cloud native database, PolarDB, to reduce maintenance time and improve uptime reliability, thus creating a smooth gamer experience.
“With added assurance for a secure gaming experience within P12 platform, we can focus our efforts on elevating the platform with quality games and sustainable economy in the fast-moving and dynamic web3 gaming industry. Alibaba Cloud’s solutions have helped us to provide our users with smoother gaming experiences and scale accordingly to peak demands with high availability and low latency,” said Boyang, founder of Project Twelve.
With Singapore as a vibrant logistics hub and it being a key pillar of the Singapore economy, Alibaba Cloud has also been working with many logistics players to deepen their digital transformation efforts. This includes JUSTI Pte. Ltd. (JUSTI), a homegrown investment holding company whose main investment portfolios includes a last mile delivery operation. Alibaba Cloud’s solutions have enabled them to digitalize and streamline its logistic networks.
“Alibaba Cloud’s AI-driven EasyDispatch solution with an embedded vehicle routing problem (VRP) capability improves our field dispatch capabilities and efficiency in real time. By utilizing Alibaba Cloud’s technologies, we can have better visibility and control over each step of our delivery chains, such as parcel status tracking, real-time AI route designing and task scheduling. They have greatly reduced our manpower cost and increase customers’ satisfaction,” said Li ChaoMing, Managing Director of JUSTI.
About Alibaba Cloud
Established in 2009, Alibaba Cloud (www.alibabacloud.com) is the digital technology and intelligence backbone of Alibaba Group. It offers a complete suite of cloud services to customers worldwide, including elastic computing, database, storage, network virtualization services, large-scale computing, security, management and application services, big data analytics, a machine learning platform and IoT services. Alibaba maintained its position as the third leading public cloud IaaS service provider globally since 2018, according to IDC. Alibaba is the world’s third leading and Asia Pacific’s leading IaaS provider by revenue in U.S. dollars since 2018, according to Gartner.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230108005098/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom